GlassScriptPhysician profile
Faruk Razzak
NPI 1558594929
$451.06
in general payments reported to CMS, 2019-2025
10 companies · $35.76 in 2025
The $35.76 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $129 · 2023: $83.91 · 2024: $202 · 2025: $35.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $133.75 | 2024 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $75.75 | 2022 | |
| Axogen | $52.48 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Scilex Pharmaceuticals INC. | $41.89 | 2023 | Ztlido |
| Bioventus LLC | $35.76 | 2025 | Gelsyn-3 |
| Depuy Synthes Sales INC. | $28.68 | 2022 | |
| Endo Pharmaceuticals INC. | $24.98 | 2022 | |
| Ferring Pharmaceuticals INC. | $23.82 | 2023 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $18.20 | 2023 | Seglentis |
| Advanced Oxygen Therapy INC. | $15.75 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faruk Razzak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.